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Summary
 
The 
 
a
 
1,3-fucosyltransferase, FucT-VII, is crucial for the formation of ligands for all three selec-
tins, and its expression regulates the synthesis of these ligands. Short-term polarized T helper
(Th)1, but not Th2 or naive CD4
 
1
 
 T cells, can home to sites of inflammation, but the molec-
ular basis for this difference has remained unclear. Here we show that naive CD4
 
1
 
 T cells do
not express FucT-VII and fail to bind vascular selectins. We also show that when CD4
 
1
 
 T cells
are activated in the presence of the Th1 polarizing cytokine interleukin (IL)-12, levels of
FucT-VII mRNA and binding to E- and P-selectin are significantly augmented. In contrast,
activation of CD4
 
1
 
 T cells in the presence of IL-4, a Th2 polarizing cytokine, inhibited FucT-
VII expression and binding to vascular selectins. T cell activation upregulated expression of the
Core2 transferase, C2GnT, equivalently regardless of the presence or absence of polarizing cy-
tokines. These data indicate that the selective ability of Th1 cells, as opposed to Th2 cells or
naive CD4
 
1
 
 T cells, to recognize vascular selectins and home to sites of inflammation is con-
trolled principally by the expression of a single gene, 
 
FucT-VII.
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T
 
he selectins are a family of carbohydrate binding adhe-
sion molecules which are essential in the regulated re-
cruitment of leukocytes to inflammatory lesions and in the
recirculation of naive lymphocytes through secondary lym-
phoid organs (1). Controlled expression of vascular selec-
tins and their ligands is critical for proper and efficient
recruitment of leukocytes to sites of tissue injury and in-
fection. All physiologic selectin ligands appear to be sialy-
lated, fucosylated, and sometimes sulfated carbohydrate
structures, the formation of which depends critically on ex-
pression of a particular 
 
a
 
1,3-fucosyltransferase (FucT-VII)
 
1
 
(2, 3). The crucial role of FucT-VII in the construction of
selectin ligands is highlighted by the severely impaired se-
lectin-dependent adhesion and in vivo leukocyte rolling of
FucT-VII–deficient animals (2). Enforced expression of
FucT-VII is sufficient for the generation of fully functional
E-selectin ligands, and is required for binding to P-selectin
(3–6). In activated T lymphocytes, expression of FucT-VII
appears to directly regulate binding to E-selectin (3).
During T cell activation, differences in the cytokine en-
vironment where T cells become activated lead to differ-
ences in their differentiation program. In the presence of
IL-12, T cells differentiate into Th1 effector cells, whereas
in the presence of IL-4 they become Th2 cells. Recent
work has suggested that Th1 and Th2 cells exhibit distinct
trafficking patterns (7). T cells which were polarized in
vitro into Th1 effector cells showed preferential recruit-
ment to cutaneous inflammatory lesions, whereas Th2 cells
were not recruited to these sites. This differential traffick-
ing appeared to result from differences in expression of
ligands for the vascular selectins (7, 8). However, the mo-
lecular basis for this difference has remained unknown.
Here, we provide evidence for the molecular mechanism
underlying the differential migration patterns of Th1 versus
 
1
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1,3-fucosyltransferase VII; PGK1,
phosphoglycerate kinase 1; RIgM, selectin-IgM; TSST-1, toxic shock
syndrome toxin-1.
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Control of FucT-VII by IL-4 and IL-12
 
Th2 and naive T cells. Naive CD4
 
1
 
 T cells, which do not
bind to vascular selectins (9, and this report) expressed no
detectable FucT-VII mRNA. Activation of T cells in the
presence of IL-12, which promotes Th1 cell development,
induced increased levels of FucT-VII mRNA and en-
hanced interactions with both E- and P-selectin. In con-
trast, activation of T cells in the presence of IL-4, which
promotes Th2 cell development, inhibited expression of
FucT-VII and binding to vascular selectins. Expression of
the glycosyltransferase, core 2 
 
b
 
1,6-
 
N
 
-acetylglucosaminyl-
transferase (C2GnT), which is required for PSGL-1 bind-
ing to P-selectin (10, 11), was easily detectable in naive T
cells and was upregulated equivalently in activated T cells
regardless of which cytokines were present. These studies
provide the first molecular explanation for the differences
in selectin binding by Th1 and Th2 cells, and give signifi-
cant insight into the mechanisms of regulation of T cell
trafficking.
 
Materials and Methods
 
mAb and Cell Lines.
 
The mAb used in these studies were as
follows: S3.1 (anti-CD4, hybridoma supernatant or FITC conju-
gate; produced in this laboratory); TS2/9.3.4.1 (anti–LFA-3, hybri-
doma supernatant; American Type Culture Collection, Rockville,
MD); UCHL-1 (anti-CD45RO, purified mAb); 2H4 (anti-
CD45RA, FITC conjugate; Coulter Immunology, Hialeah, FL);
OKT3 (anti-CD3, purified or FITC conjugate), anti-CD28 (pu-
rified; R&D Systems Inc., Minneapolis, MN), MECA-79 (rat
IgM negative control, hybridoma supernatant; American Type
Culture Collection, or purified mAb; L. Picker, University of
Texas, Dallas, TX); HECA-452 (anti-CLA, hybridoma super-
natant; American Type Culture Collection, or purified or bio-
tinylated mAb; L. Picker); goat anti–mouse IgM (FITC conju-
gate; Biosource, Camarillo, CA); goat anti–mouse IgG (FITC
conjugate; Biosource International); goat anti–human IgM (PE
conjugate; Sigma Chemical Co., St. Louis, MO). Chinese ham-
ster ovary (CHO)/E-selectin and CHO/P-selectin transfectants
were generated by transfection of CHO-K1 cells with linearized
E- or P-selectin cDNA by electroporation as described previously
(5). Stable lines expressing each selectin were selected by growth in
8 
 
m
 
g/ml puromycin, cloned by limiting dilution, and identified
by FACS
 
Ò
 
 analysis. Cloned stable transfectants were maintained
in Ham’s F12 medium supplemented with 10% FCS, 1% penicillin/
streptomycin, and 2 mM 
 
l
 
-glutamine.
 
Isolation of Normal Human CD4
 
1
 
 T Cells.
 
Cells were isolated
by standard protocols from buffy coat leukocytes obtained from
healthy volunteers. PBMCs were isolated by Ficoll-Hypaque
centrifugation and recovery of cells at the interface. CD4
 
1
 
 T cells
were isolated from PBMCs by first rosetting with neuraminidase-
treated sheep erythrocytes and recovering rosetted cells after red
cell lysis. This T cell–enriched population was then used to isolate
CD4
 
1
 
 T lymphocytes by positive panning with mAb against
CD4. The purity of the recovered cells was assessed by flow cy-
tometry, and was 
 
.
 
95% for all experiments. Naive and memory
CD4
 
1
 
 T cells were isolated by FACS
 
Ò
 
 sorting of the purified
CD4
 
1
 
 T cells after staining with FITC-conjugated UCHL-1
(anti-CD45RO), with gates set to exclude CD45RO-low cells
from both populations. Alternatively, naive CD4
 
1
 
 T cells were
isolated by positive selection on LS
 
1
 
 Magnetic Separation Col-
umns (Miltenyi Biotec Inc., Auburn, CA) of purified CD4
 
1
 
 T
cells after staining with MACS CD45RA Microbeads (Miltenyi
Biotec Inc.), according to the manufacturer’s protocol. Naive and
memory CD4
 
1
 
 T cell subpopulations were 
 
.
 
99% pure for all ex-
periments, as confirmed by FACS
 
Ò
 
 staining with FITC-conju-
gated 2H4 mAb (anti-CD45RA).
 
T Cell Activation Cultures.
 
For T cell activation, CD4
 
1
 
 T
cells were activated using either 2 
 
m
 
g/ml PHA-P (Sigma Chemi-
cal Co.) or 100 ng/ml toxic shock syndrome toxin-1 (TSST-1)
(Sigma Chemical Co.). For these experiments, cultures were ini-
tiated at 10
 
6
 
 cells/ml, 5 ml/flask, in complete media (CM) con-
taining 2% irradiated (1,500 rad) nonrosetting cells and 10 U/ml
rhIL-2 (Biosource). Where indicated, cultures also contained 100
ng/ml rhIL-4 or 0.2 ng/ml rhIL-12. As described in the text,
cells were removed at indicated time points for analysis, and me-
dia containing cytokines and stimulants were replenished as
needed.
Alternatively, 24-well plates were precoated overnight at 4
 
8
 
C
with 10 
 
m
 
g/ml anti-CD3 
 
1
 
 10 
 
m
 
g/ml anti-CD28 mAb in PBS.
Cultures were initiated with CD4
 
1
 
 T cells at 2 
 
3
 
 10
 
6
 
/ml (2 ml/
well) in RPMI 1640 (GIBCO BRL, Gaithersburg, MD) contain-
ing 5% FCS, 1% penicillin/streptomycin, and 2 mM 
 
l
 
-glutamine
(CM). T cells were incubated in mAb-coated wells for 48 h at
37
 
8
 
C (cycle 1). Where indicated, cultures also contained 100 ng/
ml rhIL-4 (Biosource) or 2 ng/ml rhIL-12 (R&D Systems), and
these cytokines were present throughout the activation protocol;
however, IL-2 was not present during mAb activation, and was
included only during the expansion phase of the protocol, when
cells were incubated without mAb (see below). After 48 h, cells
were removed from mAb-coated wells, washed, and diluted to 5 
 
3
 
10
 
5
 
 cells/ml in CM containing 10 U/ml IL-2 (Biosource). IL-4
or IL-12 was also included, as indicated. Cells were expanded for
5–6 d, and the cell concentration was maintained at 5 
 
3
 
 10
 
5
 
cells/ml by diluting the cultures daily with fresh cytokine-con-
taining media. After 5–6 d, cells were washed and reactivated for
18 h with plate-bound anti-CD3 
 
1
 
 anti-CD28 (cycle 2), again in
the absence of IL-2. After 18 h, cells were removed from plates,
washed, and diluted to 5–10 
 
3
 
 10
 
5
 
 cells/ml in CM containing
IL-2 and IL-4 or IL-12, as indicated. Cells were again expanded
in cytokine-containing media for 2–5 d, maintaining the cell
concentration between 5 and 10 
 
3
 
 10
 
5
 
. At the indicated time
points, cells were removed from cultures for FACS
 
Ò
 
 analysis, re-
verse transcriptase (RT)-PCR analysis, or rolling assays.
 
Semiquantitative RT-PCR.
 
Detection of FucT-VII, C2GnT,
and phosphoglycerate kinase 1 (PGK1) mRNA by RT-PCR was
performed as described elsewhere (5). In brief, total cellular RNA
was isolated from 10
 
7
 
 cells, and 1 
 
m
 
g total RNA was used as tem-
plate in a 20-
 
m
 
l RT reaction. PCR amplification of cDNA was
carried out with cycle numbers previously titered to be well be-
low the plateau phase of amplification to give an accurate reflec-
tion of the relative starting concentration of mRNA. For PGK1
detection 25 cycles were used, for C2GnT detection 28 cycles
were used, and for FucT-VII detection 33 cycles were used. Each
cycle consisted of 30 s at 94
 
8
 
C, 30 s at 68
 
8
 
C, and 30 s at 72
 
8
 
C.
For detection of FucT-VII mRNA, the sense primer 5
 
9
 
-CCC
ACC GTG GCC CAG TAC CGC TTC T-3
 
9
 
 and the antisense
primer 5
 
9
 
-CTG ACC TCT GTG CCC AGC CTC CCG T-3
 
9
 
were used. For C2GnT detection, the sense primer 5
 
9
 
-TTT TCW
GGC AGT GCC TAC TTC GTG GTC-3
 
9
 
 and the antisense
primer 5
 
9
 
-ATG CTC ATC CAA ACA CTG GAT GGC AAA-3
 
9
 
were used, where W 
 
5
 
 50% A, 50% T. For PGK1 detection, the
sense primer 5
 
9
 
-ATG ATT ATT GGT GGT GGA ATG GCT-
3
 
9
 
 and the antisense primer 5
 
9
 
-TCA TCC ATG AGA GCT TTG
GTT CC-3
 
9
 
 were used. To enhance comparisons between differ- 
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ent groups of activated CD4
 
1
 
 T cells, some PCR reactions were
carried out as above using twofold serial dilutions of the input
cDNA. PCR products were detected by agarose gel electrophore-
sis and Southern blotting, as described previously (5).
 
Flow Cytometry.
 
FACS
 
Ò
 
 analysis was performed as described
elsewhere (5). mAbs for FACS
 
Ò
 
 were used at empirically deter-
mined optimal dilutions. For detection of E- and P-selectin
ligands by flow cytometry, E- and P-selectin IgM chimeras (2)
were obtained from Dr. John Lowe (Howard Hughes Medical
Institute, University of Michigan, Ann Arbor, MI). Selectin-IgM
(RIgM) chimeras were collected from the media of COS cells
transfected with chimera expression vectors, and used to detect
selectin ligands on resting and activated CD4
 
1
 
 T cells. 5 
 
3
 
 10
 
5
 
cells were incubated in 100 
 
m
 
l E-RIgM supernatant (undiluted)
or 5 
 
m
 
g/ml purified P-RIgM protein for 15 min at 4
 
8
 
C. Cells
were washed once with 100 
 
m
 
l DME (GIBCO BRL) containing
1% serum and 0.1% NaN
 
3
 
. Pellets were resuspended in 100 
 
m
 
l of
PE-conjugated goat anti–human IgM (Sigma Chemical Co.) di-
luted 1:50 in DME/1% serum, and incubated for 15 min at 4
 
8
 
C.
Cells were again washed with 100 
 
m
 
l DME/1% serum/0.1%
NaN
 
3
 
, and resuspended in this media for FACS
 
Ò
 
 analysis. For all
analyses, data were collected on a FACScan
 
Ò
 
 or FACSCalibur
 
Ò
 
flow cytometer (Becton Dickinson, Mountain View, CA) and
analyzed with CellQuest software. Histograms of relative fluores-
cence intensity were analyzed and data are presented as the per-
centage of cells staining for the indicated epitope, as determined
by the position of the negative control histogram.
 
Low Shear Adhesion Assays.
 
Binding of cells to E- or P-selectin
under low shear conditions was determined as described previ-
ously (4, 5). In brief, cells were allowed to adhere to COS cells
transiently transfected with either E- or P-selectin with low shear
generated by constant rocking. The data are presented as the
mean number of cells bound per COS cell 
 
6
 
 SEM.
 
In Vitro Rolling Assays.
 
Adhesion of cells to E- or P-selectin
was determined in a parallel plate flow chamber (CytoDyne Inc.,
San Diego, CA) at a shear stress of 1.7 dyn/cm
 
2
 
. Shear stress in
the chamber was controlled by regulating the fluid flow rate by
adjusting the height of a raised reservoir connected to the inlet
port. The required flow rate was calculated for a given shear stress
by the following equation: 
 
SS
 
 
 
5
 
 6
 
Q
 
m
 
/
 
bh
 
2
 
, where 
 
SS
 
 
 
5
 
 shear
stress (dyn/cm
 
2), Q 5 flow rate (cm3/s), m 5 fluid viscosity (dyn 3
s/cm2), b 5 channel width (cm), and h 5 channel height (cm).
Activated CD41 T lymphocytes were perfused through the
chamber at 5 3 104 cells/ml in RPMI 1640 containing 0.1% se-
rum. Phase–contrast images of T cells rolling on monolayers of
CHO cell transfectants expressing either E-selectin or P-selectin
were obtained using a Nikon Diaphot 300 microscope equipped
with a 103 objective and a Hamamatsu Argus 20 CCD camera
and image processor, and recorded on videotape for offline analy-
sis. Data are expressed as numbers of interacting cells/field/min,
and are averaged for at least 10 different fields of view.
Statistical Analysis. For those data which satisfied the normal-
ity test, adhesion data were analyzed by one-way ANOVA with
the Bonferroni correction. For data which failed the normality
test, the nonparametric Kruskall-Wallis one-way ANOVA was
used, with Dunn’s method for pair-wise analysis. Differences
were considered statistically significant with P , 0.05.
Results and Discussion
Naive CD41 T Cells Do Not Express Detectable FucT-VII
mRNA and Fail to Bind Vascular Selectins. The critical role
of FucT-VII in the generation of selectin ligands (2) sug-
gested that the absence of this enzyme may represent the
molecular basis for the failure of naive cells to bind to vas-
cular selectins. Therefore, we analyzed purified unfraction-
ated, naive (CD45RO-negative), and memory (CD45RO-
high) CD41 T cells for expression of FucT-VII mRNA by
semiquantitative RT-PCR. Naive CD41 T cells expressed
no detectable FucT-VII mRNA, whereas unfractionated
CD4 cells and memory T cells expressed FucT-VII mRNA
at significant levels (Fig. 1 A). To further confirm the lack
Figure 1. Naive CD41 T cells
do not express FucT-VII and do
not bind to vascular selectins. (A)
Expression of FucT-VII and
C2GnT mRNA by unfraction-
ated, naive, and memory CD41
T lymphocytes was determined
by semiquantitative RT-PCR
analysis, as described in Materi-
als and Methods. RT indicates
reverse transcriptase; 1 indicates
reactions in which RT was in-
cluded; 2 indicates control reac-
tions in which RT was omitted.
PGK1 is a housekeeping gene
used as an internal control for the
RT reaction. (B) Expression of
HECA-452 mAb epitope by pu-
rified naive and memory CD41
T lymphocytes was determined
by FACSÒ analysis. Numbers in
the upper right corner of each
histogram indicate the percent
HECA-452 positive cells in each
population. (C) Binding of un-
fractionated, naive, and memory CD41 T lymphocytes to COS cells transiently transfected with E-selectin (solid bars) or P-selectin (gray bars). Data are
presented as mean numbers of lymphocytes bound per COS cell 6 SEM.2228 Control of FucT-VII by IL-4 and IL-12
of FucT-VII activity in naive CD41 T cells, we analyzed
purified naive and memory cells by flow cytometry for ex-
pression of HECA-452 antigen (CLA), which identifies
FucT-VII reporter epitopes whose level of expression
above a certain threshold corresponds well to the level of
FucT-VII expression (3, 5, 6). Analysis with HECA-452
mAb also allows estimation of FucT-VII activity on a per
cell basis, whereas RT-PCR analysis represents the average
of expression across an entire population. As described pre-
viously (12, 13), naive CD41 cells failed to stain apprecia-
bly with HECA-452 mAb, whereas z15–20% of CD41
memory cells were positive for this epitope (Fig. 1 B).
Consistent with previous reports (9) and the absence of de-
tectable FucT-VII (Fig. 1 A), naive CD41 T cells also failed
to interact appreciably with either E-selectin or P-selectin in
a sensitive low shear assay (Fig. 1 C). In contrast, both un-
fractionated CD41 cells and purified memory T cells ex-
hibited significantly higher (P , 0.05) levels of binding to
both E- and P-selectin. Thus, naive T cells do not express
FucT-VII, which is sufficient to explain their inability to
bind vascular selectins. These data indicate that upregula-
tion of FucT-VII expression may be directly responsible for
the acquisition of E- and P-selectin binding ability by acti-
vated and memory CD41 T cells.
Th1 Cells Express Much Higher Levels of FucT-VII mRNA
Than Th2 Cells. Austrup et al. recently identified a strik-
ing difference in the ability of short-term polarized Th1
versus Th2 cells to migrate to inflammatory sites in vivo
(7), which they have attributed to differences in expression
of selectin ligands by these cells (8). To investigate whether
differences in FucT-VII expression were responsible for
these differences, purified CD41 T cells were activated
with PHA in the presence of either IL-2 alone (nonpolariz-
ing), IL-2 1 IL-4 (Th2-polarizing), or IL-2 1 IL-12 (Th1-
polarizing), and the relative level of expression of FucT-VII
mRNA was determined for each condition (Fig. 2). FucT-
VII mRNA levels were higher in Th1-type cells than in
freshly isolated CD41 T cells or T cells activated with IL-2
alone. In contrast, the level of FucT-VII mRNA expressed
by Th2-type cells was reduced sharply when compared
with levels of FucT-VII expressed by unstimulated or IL-2
activated cells (Fig. 2 A). Detailed analysis of these samples
by twofold serial dilution of the input cDNA (Fig. 2 B) in-
dicated that Th1 cells exhibited .30-fold higher amounts
of steady-state FucT-VII mRNA than Th2 cells, and .30-
fold higher levels than fresh CD41 T cells. CD41 T cells
activated with IL-2 alone showed approximately fourfold
higher levels of FucT-VII than Th2 cells, and approxi-
Figure 2. Effect of Th1 or Th2 polarizing condi-
tions on expression of FucT-VII and C2GnT
mRNA. RNA was isolated from fresh CD41 T
lymphocytes or after activation with PHA and cul-
ture with IL-2 alone, IL-2 1 IL-4, or IL-2 1 IL-
12. (A) Expression of FucT-VII and C2GnT
mRNA was determined by semiquantitative RT-
PCR, as in Fig. 1. (B) A more detailed analysis of
FucT-VII and C2GnT expression was carried out
using twofold serial dilutions of input cDNA, using
the same amount of cDNA in the first (left) lane as
in A. Amounts of input cDNA decrease to the left,
as indicated above the blots. The lanes on the right
(2RT) are the negative controls in which the RT
is omitted from the RT reaction.2229 Wagers et al.
mately four- to eightfold lower levels than Th1 cells, and
reproducibly exhibited higher levels of FucT-VII mRNA
than fresh, resting CD4 cells. A similar analysis after activa-
tion of CD41 T cells with plate-bound anti-CD3/anti-
CD28 revealed a similar pattern of induction of FucT-VII
in Th1 cells and inhibition of FucT-VII in Th2 cells (data
not shown). Thus, these data strongly support the hypothe-
sis that IL-12 induces higher levels of FucT-VII mRNA in
activated T cells, whereas IL-4 downregulates FucT-VII
expression, probably at the level of transcription.
To investigate the time course of FucT-VII induction or
inhibition in Th1 and Th2 polarized T cells, purified naive
CD41 T cells or unfractionated CD41 T cells were acti-
vated in the presence of either IL-4 or IL-12, and expres-
sion of FucT-VII reporter epitopes, defined by HECA-452,
was used to monitor FucT-VII activity. After activation
with anti-CD3/anti-CD28, naive CD41 T cells cultured
with IL-2 alone showed little induction of HECA-452
reactivity; however, addition of IL-12 to the cultures in-
duced approximately threefold more HECA-452 staining
(Fig. 3 A). In contrast, naive CD41 T cells cultured in the
presence of IL-4 showed reduced staining with HECA-452
mAb. These Th2-type cells showed approximately two- to
threefold decreased reactivity with HECA-452 as com-
pared with cells activated in the presence of IL-2 alone, and
approximately ninefold less HECA-452 staining as com-
pared with Th1-type T cells. Th1- and Th2-polarizing cy-
tokines had similar effects on FucT-VII activity in cultures
of unfractionated CD41 T cells, which would be expected
to contain both naive and memory/activated T cell subsets.
As in cultures of naive cells, CD41 T cells activated in the
presence of IL-2 alone showed some induction of HECA-
452 reactivity (Fig. 3 B). Addition of IL-12 induced two-
to threefold more HECA-452 staining, whereas culture with
IL-4 clearly inhibited HECA-452 reactivity (approximately
fourfold as compared with cells cultured with IL-2 alone).
Ultimately, the opposite effects of IL-4 and IL-12 on T cell
FucT-VII activity led to an approximately five- to seven-
fold difference in HECA-452 reactivity in Th1- versus
Th2-type T cells. Importantly, the observed differences in
HECA-452 reactivity were not dependent on the type of
stimulus, as a similar pattern was observed when CD41 T
cells were activated with PHA (Fig. 3 C) or with the super-
antigen TSST-1 (Fig. 3 D).
C2GnT is required for leukocyte adhesion to P-selectin
(10, 11). In contrast with FucT-VII, naive cells expressed
easily detectable C2GnT mRNA (Fig. 1 A), and the levels
of C2GnT mRNA increased equivalently upon activation,
independent of which cytokines were present (Fig. 2 A).
Twofold serial dilution of input cDNA revealed little if
any difference in C2GnT mRNA levels between Th1,
Th2, and unpolarized CD41 T cells, but C2GnT levels
were generally at least 8–16-fold higher in activated cells
than in fresh CD41 T cells (Fig. 2 B). Increased expression
of C2GnT could represent a secondary mechanism for
regulation of P-selectin binding in activated or memory
CD41 T cells. However, the lack of differential regulation
of C2GnT expression during Th1 or Th2 differentiation
underscores the critical role of FucT-VII in determining
the differences in selectin binding by Th1- and Th2-type
cells.
Expression of FucT-VII Directly Correlates with Binding to
E- and P-selectin. We analyzed the ability of anti-CD3/
anti-CD28 activated CD41 T cells to interact with E- and
P-selectin by FACSÒ analysis with RIgM chimera proteins
(Fig. 4, A and B) and in a parallel plate flow chamber under
defined laminar shear stress (Fig. 4, C and D). The data
show a direct correlation of FucT-VII expression with the
ability to bind E- and P-selectin. By FACSÒ analysis, staining
with E-RIgM and P-RIgM chimeras paralleled HECA-452
reactivity, as Th1-type cells showed increased reactivity with
both E- and P-RIgM, whereas Th2-type cells showed de-
creased staining with the chimera proteins (Fig. 4, A and
B). Similarly, in in vitro flow assays, Th1-type cells showed
significantly (P  ,  0.05) greater numbers of interactions
with E-selectin than T cells cultured with IL-2 alone,
whereas Th2-type cells showed significantly (P , 0.05) di-
minished rolling interactions (Fig. 4 C). Cells activated
with IL-2 1 IL-12 exhibited z4.5-fold more rolling inter-
actions than cells activated with IL-2 1 IL-4 (P , 0.05).
Similar differences were observed for rolling on P-selectin
(Fig. 4 D), where the differences were smaller (z2.5-fold)
but still significant (P , 0.05), consistent with the much
greater sensitivity of binding to E-selectin to levels of
FucT-VII (6, 14). Similar results were obtained when T
cells were activated with PHA-P (data not shown). These
data indicate that cytokine-directed changes in FucT-VII
Figure 3. HECA-452 reactivity of CD41 T cells in response to varying
culture conditions. HECA-452 staining of FucT-VII reporter epitopes (5)
was used to assess FucT-VII activity. Naive CD41 T cells (A) or unfrac-
tionated CD41 T cells (B–D) were activated with either anti-CD3/anti-
CD28 (A and B), PHA-P (C), or TSST-1 (D). In all panels, squares de-
note cultures containing IL-2 alone, diamonds denote cultures containing
IL-2 1 IL-4, and circles denote cultures containing IL-2 1 IL-12. Data
are presented as percent HECA-452 positive lymphocytes for each cul-
ture condition at the indicated time point.2230 Control of FucT-VII by IL-4 and IL-12
expression underlie the distinct adhesive capacities of Th1
and Th2 cells.
Taken together, these data demonstrate a direct and sig-
nificant effect of Th1 and Th2 polarizing cytokines on
binding to E- and P-selectin, and indicate that this effect is
mediated through changes in FucT-VII gene expression.
Our findings provide a molecular basis for the ability of
short-term polarized Th1 but not Th2 or naive CD41 T
cells to interact with vascular selectins and to home to sites
of inflammation in vivo. Thus, IL-12, in addition to pro-
moting the differentiation of CD41 T cells into Th1 cells,
also induces expression of FucT-VII. In contrast, IL-4,
while initiating differentiation into a Th2 phenotype, in-
hibits expression of FucT-VII. These changes in FucT-VII
coordinately affect the ability of the T cell to synthesize and
express ligands for vascular selectins, and thus underlie the
differences observed in Th1 and Th2 cells in binding to E-
and P-selectin. Importantly, other glycosyltransferases im-
portant for selectin ligand construction, particularly C2GnT
(Fig. 2, A and B) and FucT-IV (data not shown), do not
appear to be differentially regulated by IL-12 and IL-4, fur-
ther emphasizing the key regulatory role of FucT-VII in
expression of functional selectin ligands.
Several investigators have examined the regulation of the
migratory capacities of T lymphocytes as a function of acti-
vation and differentiation. In addition to differential inter-
actions of newly polarized Th1 versus Th2 cells with E-
and P-selectin (7, 8), expression of receptors for several
chemokines appears to be differentially regulated among
Th1 and Th2 cells (15–18). Thus, the accumulating evi-
dence suggests that there will be several control points in
determining the trafficking patterns of different subtypes of
CD41 T lymphocytes, reflecting defined steps in the multi-
step cascade of leukocyte–endothelial cell interactions (19).
Recent evidence suggests that the effects of IL-12 in upreg-
ulating FucT-VII may be important in the regulation of se-
lectin binding in multiple classes of leukocytes, as similar
effects of IL-12 are seen in CD81 T lymphocytes (our un-
published observations) and in NK cells (20). The require-
ment for FucT-VII expression in construction of selectin
ligands, and thus in efficient leukocyte recruitment to pe-
ripheral inflammatory sites, makes downregulation of this
enzyme’s activity an attractive target for therapeutic inter-
vention aimed at blockade of chronic inflammatory disease.
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Figure 4. Binding of Th1- or Th2-type cells to E- and P-selectin. (A
and B) Expression of selectin ligands by anti-CD3/anti-CD28 activated
CD41 T lymphocytes was determined by flow cytometry using RIgM
chimera proteins. Data are presented as percentage of cells staining with
E-RIgM (A) or P-RIgM (B) chimera for each culture condition at the in-
dicated time point. Squares denote cultures containing IL-2 alone, dia-
monds denote cultures containing IL-2 1 IL-4, and circles denote cul-
tures containing IL-2 1 IL-12. (C and D) Binding of activated CD41 T
cells to vascular selectins was assessed in in vitro rolling assays at 1.7 dyn/
cm2. Cells were activated with anti-CD3/anti-CD28 and analyzed 2 d af-
ter the second activation. HECA-452 reactivity of the analyzed cells was
as follows: IL-2 only, 32.7% positive; IL-2 1 IL-4, 9.9% positive; IL-2 1
IL-12, 48.3% positive. Data are expressed as the mean number of rolling
cells/field/min 6 SD for at least 10 different fields of view. (C) Rolling
interactions of CD41 T lymphocytes on CHO/E-selectin monolayers.
(D) Rolling interactions of CD41 T lymphocytes on CHO/P-selectin
monolayers. (*, **) For each selectin, differences in rolling among unpo-
larized, Th1-, and Th2-type CD41 T cell groups were statistically signifi-
cant (P , 0.05).
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